Dan Atar
- Professor; MD PhD
- +47 22 11 91 00
Mini CV
Education: He graduated from Basel University, trained in internal medicine and cardiology in Switzerland, Denmark, and the US, and held a post-doc position at the Johns Hopkins University in Baltimore (1991-94)
Work record:
- Head of Research at the Div. of Medicine and Professor of Cardiology at the Oslo University Hospital in Norway. 2013 - present
- Head of Cardiology Ullevål University Hospital, 2010 to 2013
- Head of Cardiology at Aker University Hospital, 2002 to 2010
- Visiting Associate Professorship at the Johns Hopkins University in Baltimore, USA.
- Co-authored over 540 articles (H-index 82)
Awards, committees, memberships:
- Fellowships: FESC, FACC, FEHRA and inaugural FAHA.
- Previous Chairman of the ESC Working Group on CV Pharmacotherapy.
- Chair of an EUFP7 research consortium (Mitocare) to study reperfusion injury in STEMI.
- He was on several ESC guideline writing committees, amongst others the 2010, 2012 and 2016 ESC AFib Guidelines as well as the 2012 STEMI-guideline and the 2018 Universal Definition of MI.
- Elected as Councilor and Board member of the ESC, as its Vice President, And as Treasurer of the ESC.
- He earned a doctor honoris causa in 2015 and in
- 2016 on the Clarivate list of “the most cited researchers of the world”.
- In 2023 he received the "Lifetime Achievement Award in Heart Research" by the Norwegian Association for Public Health".
Research areas:
- Cardiovascular pharmacotherapy
- Atrial fibrillation
- Acute coronary syndromes
- Cardiac function and heart failure
Publications 2024
The Interplay of Atherothrombotic Factors and the Evolving Landscape of Atherosclerotic Cardiovascular Disease: Comprehensive Insights from Recent Studies
Anatol J Cardiol, 28 (8), 375-80 (in press)
DOI 10.14744/AnatolJCardiol.2024.4632, PubMed 39011832
Elective direct current cardioversion of atrial fibrillation - silent brain infarction and health related quality of life
Cardiology (in press)
DOI 10.1159/000540007, PubMed 39025051
Statin discontinuation: How can we improve on the multiple pathways that contribute to suboptimal statin adherence?
Kardiol Pol (in press)
DOI 10.33963/v.phj.102335, PubMed 39240921
Moral distress and protective work environment for healthcare workers during public health emergencies
BMC Med Ethics, 25 (1), 103
DOI 10.1186/s12910-024-01098-w, PubMed 39354454
The NORwegian atrial fibrillation self-SCREENing (NORSCREEN) trial: rationale and design of a randomized controlled trial
Europace, 26 (10)
DOI 10.1093/europace/euae228, PubMed 39248170
Platelet activity, coagulation, and fibrinolysis in long-term users of anabolic-androgenic steroids compared to strength-trained athletes
Thromb Res, 238, 60-66
DOI 10.1016/j.thromres.2024.04.027, PubMed 38676967
Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on Thrombosis
Eur Heart J Cardiovasc Pharmacother, 10 (7), 614-645
DOI 10.1093/ehjcvp/pvae064, PubMed 39237457
Health care workers' qualitative descriptions of ethically challenging situations evoking moral distress during Covid-19
Nurs Ethics, 31 (8), 1709-1721
DOI 10.1177/09697330241257567, PubMed 38855850
The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristics
Eur Heart J Cardiovasc Pharmacother, 10 (3), 175-183
DOI 10.1093/ehjcvp/pvad093, PubMed 38017624
Imaging features for the identification of atrial fibrillation in cryptogenic stroke patients
J Neurol, 271 (8), 5343-5356
DOI 10.1007/s00415-024-12397-y, PubMed 38904781
Antithrombotic therapy in patients with acute coronary syndrome: similarities and differences between a European expert consensus document and the 2023 European Society of Cardiology guidelines
Eur Heart J Acute Cardiovasc Care, 13 (1), 173-180
DOI 10.1093/ehjacc/zuad158, PubMed 38170562
Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiA
J Am Coll Cardiol, 84 (4), 354-364
DOI 10.1016/j.jacc.2024.05.002, PubMed 39019530
Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary Disease
J Am Coll Cardiol, 83 (6), 652-664
DOI 10.1016/j.jacc.2023.11.029, PubMed 38325990
Short-Term Effects of Lower Air Temperature and Cold Spells on Myocardial Infarction Hospitalizations in Sweden
J Am Coll Cardiol, 84 (13), 1149-1159
DOI 10.1016/j.jacc.2024.07.006, PubMed 39230547
Contractility, ventriculoarterial coupling, and stroke work after acute myocardial infarction using CMR-derived pressure-volume loop data
Clin Cardiol, 47 (1), e24216
DOI 10.1002/clc.24216, PubMed 38269628
De-escalation of antithrombotic treatment after acute coronary syndrome, a new paradigm
Intern Emerg Med, 19 (6), 1537-1548
DOI 10.1007/s11739-024-03590-y, PubMed 38594458
Screening for Atrial Fibrillation by Digital Health Technology in Older People in Homecare Settings: A Feasibility Trial
Int J Telemed Appl, 2024, 4080415
DOI 10.1155/2024/4080415, PubMed 38567031
Digital recruitment and compliance to treatment recommendations in the Norwegian Atrial Fibrillation self-screening pilot study
Eur Heart J Digit Health, 5 (3), 371-378
DOI 10.1093/ehjdh/ztae026, PubMed 38774377
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials
Eur Heart J (in press)
DOI 10.1093/eurheartj/ehae596, PubMed 39222018
Publications 2023
Recurrent pericarditis
Tidsskr Nor Laegeforen, 143 (8)
DOI 10.4045/tidsskr.22.0580, PubMed 37254974
Cardiac device infection: removing barriers to timely and adequate treatment
Eur Heart J, 44 (35), 3323-3326
DOI 10.1093/eurheartj/ehad490, PubMed 37529893
Achieving the unachievable: How to optimize lipid-lowering therapy in survivors of acute myocardial infarction
Kardiol Pol, 81 (4), 327-329
DOI 10.33963/KP.a2023.0087, PubMed 37144720
Implementing screening for myocardial injury in non-cardiac surgery: perspectives of an ad-hoc interdisciplinary expert group
Scand Cardiovasc J, 57 (1), 31-39
DOI 10.1080/14017431.2022.2112071, PubMed 37141087
"I've kept going" - a multisite repeated cross-sectional study of healthcare workers' pride in personal performance during the COVID-19 pandemic
BMC Health Serv Res, 23 (1), 322
DOI 10.1186/s12913-023-09246-5, PubMed 37004056
Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitus
Clin Res Cardiol, 113 (6), 822-830
DOI 10.1007/s00392-023-02268-3, PubMed 37608126
Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE
Circulation, 147 (16), 1192-1203
DOI 10.1161/CIRCULATIONAHA.122.063399, PubMed 36779348
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
N Engl J Med, 390 (2), 107-117
DOI 10.1056/NEJMoa2310234, PubMed 37952132
The Effects of Exercise Training in Patients With Persistent Dyspnea Following Pulmonary Embolism: A Randomized Controlled Trial
Chest, 164 (4), 981-991
DOI 10.1016/j.chest.2023.04.042, PubMed 37149257
Prognostic utility and characterization of left ventricular hypertrophy using global thickness
Sci Rep, 13 (1), 22806
DOI 10.1038/s41598-023-48173-7, PubMed 38129418
Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)
Eur Heart J Cardiovasc Pharmacother, 9 (3), 271-290
DOI 10.1093/ehjcvp/pvad016, PubMed 36869784
Adapter CAR T cells to counteract T-cell exhaustion and enable flexible targeting in AML
Leukemia, 37 (6), 1298-1310
DOI 10.1038/s41375-023-01905-0, PubMed 37106163
Rhythm versus rate control in patients with newly diagnosed atrial fibrillation - Observations from the GARFIELD-AF registry
Int J Cardiol Heart Vasc, 49, 101302
DOI 10.1016/j.ijcha.2023.101302, PubMed 38020059
Prediction of underlying atrial fibrillation in patients with a cryptogenic stroke: results from the NOR-FIB Study
J Neurol, 270 (8), 4049-4059
DOI 10.1007/s00415-023-11680-8, PubMed 37162578
Underlying causes of cryptogenic stroke and TIA in the nordic atrial fibrillation and stroke (NOR-FIB) study - the importance of comprehensive clinical evaluation
BMC Neurol, 23 (1), 115
DOI 10.1186/s12883-023-03155-0, PubMed 36944929
Fully digital self-screening for atrial fibrillation with patch electrocardiogram
Europace, 25 (5)
DOI 10.1093/europace/euad075, PubMed 36945146
RESPONSE: Climate Change and Health: Challenges, Opportunities, and the Need for Action
J Am Coll Cardiol, 81 (11), 1130-1132
DOI 10.1016/j.jacc.2022.10.041, PubMed 36922095
[PCSK9 inhibitors on reimbursable prescription: who is eligible?]
Tidsskr Nor Laegeforen, 143 (8)
DOI 10.4045/tidsskr.23.0191, PubMed 37254976
Time Course of Death After Acute Coronary Syndrome Treated With Dual Antiplatelet Therapy for 1 Year
Am J Med, 136 (5), 484-488
DOI 10.1016/j.amjmed.2023.01.029, PubMed 36828207
Strokes and Transient Ischemic Attacks Occurrence During Annual Dual Antiplatelet Therapy
Am J Ther, 30 (5), e411-e415
DOI 10.1097/MJT.0000000000001622, PubMed 37713684
Biomarkers predictive of atrial fibrillation in patients with cryptogenic stroke. Insights from the Nordic Atrial Fibrillation and Stroke (NOR-FIB) study
Eur J Neurol, 30 (5), 1352-1363
DOI 10.1111/ene.15746, PubMed 36786305
Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease
Eur Heart J Cardiovasc Pharmacother, 9 (5), 462-496
DOI 10.1093/ehjcvp/pvad032, PubMed 37120728
Publications 2022
Do we need new lipid-lowering agents in the era of PCSK9 inhibitors? Recent advances
Kardiol Pol, 80 (7-8), 741-749
DOI 10.33963/KP.a2022.0117, PubMed 35521719
Randomized, open-label, crossover trial comparing the pharmacokinetic profile of a novel oral aspirin solution and a chewed aspirin tablet
Int J Clin Pharmacol Ther, 60 (10), 430-438
DOI 10.5414/CP204271, PubMed 35979901
The Role of ECG in the Diagnosis and Risk Stratification of Acute Coronary Syndromes: an Old but Indispensable Tool
Curr Cardiol Rep, 24 (2), 109-118
DOI 10.1007/s11886-021-01628-7, PubMed 35028816
Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction
J Am Coll Cardiol, 80 (12), 1130-1143
DOI 10.1016/j.jacc.2022.06.037, PubMed 36050227
Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial
Eur Heart J Cardiovasc Pharmacother, 8 (3), 227-235
DOI 10.1093/ehjcvp/pvaa140, PubMed 33367487
Cardiovascular phenotype of long-term anabolic-androgenic steroid abusers compared with strength-trained athletes
Scand J Med Sci Sports, 32 (8), 1170-1181
DOI 10.1111/sms.14172, PubMed 35460300
The Association of Smoking with Hospitalization and Mortality Differs According to Sex in Patients with Heart Failure Following Myocardial Infarction
J Womens Health (Larchmt), 31 (3), 310-320
DOI 10.1089/jwh.2021.0326, PubMed 35049355
Infarct quantification with cardiovascular magnetic resonance using "standard deviation from remote" is unreliable: validation in multi-centre multi-vendor data
J Cardiovasc Magn Reson, 24 (1), 53
DOI 10.1186/s12968-022-00888-8, PubMed 36336693
Cost-effectiveness of a rule-out algorithm of acute myocardial infarction in low-risk patients: emergency primary care versus hospital setting
BMC Health Serv Res, 22 (1), 1274
DOI 10.1186/s12913-022-08697-6, PubMed 36271364
Performance of the Novel Observation Group Criteria of the European Society of Cardiology (ESC) 0/1-Hour Algorithm in a Low-Risk Population
J Am Heart Assoc, 11 (7), e024927
DOI 10.1161/JAHA.121.024927, PubMed 35352564
No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab
PLoS One, 17 (4), e0266615
DOI 10.1371/journal.pone.0266615, PubMed 35404972
CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical research
Lancet Digit Health, 4 (10), e757-e764
DOI 10.1016/S2589-7500(22)00151-0, PubMed 36050271
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research
BMJ, 378, e069048
DOI 10.1136/bmj-2021-069048, PubMed 36562446
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research
Eur Heart J, 43 (37), 3578-3588
DOI 10.1093/eurheartj/ehac426, PubMed 36208161
Cost-Minimization Analysis for Cardiac Revascularization in 12 Health Care Systems Based on the EuroCMR/SPINS Registries
JACC Cardiovasc Imaging, 15 (4), 607-625
DOI 10.1016/j.jcmg.2021.11.008, PubMed 35033498
Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease
Circulation, 146 (15), 1109-1119
DOI 10.1161/CIRCULATIONAHA.122.061620, PubMed 36031810
Cryptogenic stroke and TIA: Suggested diagnostic approach while waiting for evaluation and treatment guidelines
Acta Neurol Scand, 145 (5), 641-646
DOI 10.1111/ane.13590, PubMed 35146751
Atrial fibrillation in cryptogenic stroke and TIA patients in The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Main results
Eur Stroke J, 8 (1), 148-156
DOI 10.1177/23969873221123122, PubMed 37021182
Atrial fibrillation in cryptogenic stroke and TIA patients in The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Main results
European Stroke Journal, 0 (0), 1-9
DOI 10.1177/23969873221123122, PublikaID 431
Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction
Eur J Heart Fail, 24 (5), 782-790
DOI 10.1002/ejhf.2468, PubMed 35239245
Impact of Bleeding on Myocardial Infarction, Stroke, and Death During 12 Months Dual Antiplatelet Therapy After Acute Coronary Syndrome
Am J Med, 135 (11), 1342-1348
DOI 10.1016/j.amjmed.2022.07.022, PubMed 35977606
Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS-ADONIS trials
Clin Cardiol, 45 (1), 101-109
DOI 10.1002/clc.23765, PubMed 35019175
A Comprehensive Review of the Pleiotropic Effects of Ticagrelor
Cardiovasc Drugs Ther, 38 (4), 775-797
DOI 10.1007/s10557-022-07373-5, PubMed 36001200
Do We Really Need Aspirin Loading for STEMI?
Cardiovasc Drugs Ther, 36 (6), 1221-1238
DOI 10.1007/s10557-022-07327-x, PubMed 35171384
Publications 2021
Why Not Dipyridamole: a Review of Current Guidelines and Re-evaluation of Utility in the Modern Era
Cardiovasc Drugs Ther, 36 (3), 525-532
DOI 10.1007/s10557-021-07224-9, PubMed 34245446
New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?
Atherosclerosis, 319, 51-61
DOI 10.1016/j.atherosclerosis.2020.12.013, PubMed 33476944
Is RBBB the new LBBB? Are we going to repeat the same mistakes?
J Electrocardiol, 65, 34-36
DOI 10.1016/j.jelectrocard.2020.12.010, PubMed 33477070
Use of Non-vitamin K Antagonist Oral Anticoagulants for Stroke Prevention across the Stroke Spectrum: Progress and Prospects
Thromb Haemost, 121 (6), 716-730
DOI 10.1055/s-0040-1721665, PubMed 33412613
Performance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction : An International Collaborative Meta-analysis
Ann Intern Med, 175 (1), 101-113
DOI 10.7326/M21-1499, PubMed 34807719
MVnet: automated time-resolved tracking of the mitral valve plane in CMR long-axis cine images with residual neural networks: a multi-center, multi-vendor study
J Cardiovasc Magn Reson, 23 (1), 137
DOI 10.1186/s12968-021-00824-2, PubMed 34857009
The Times They Are A-Changin´: Antithrombotic strategies in patients with acute coronary syndrome undergoing coronary stenting who have concomitant atrial fibrillation
Eur J Intern Med, 88, 21-22
DOI 10.1016/j.ejim.2021.04.008, PubMed 33934970
Comparison of a single high-sensitivity cardiac troponin T measurement with the HEART score for rapid rule-out of acute myocardial infarction in a primary care emergency setting: a cohort study
BMJ Open, 11 (2), e046024
DOI 10.1136/bmjopen-2020-046024, PubMed 33627355
Efficacy of Long-Term Oral Beta-Blocker Therapy in Patients Who Underwent Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction With Preserved Left Ventricular Ejection Fraction: A Systematic Review and Meta-analysis
J Cardiovasc Pharmacol, 77 (1), 87-93
DOI 10.1097/FJC.0000000000000922, PubMed 33136764
The perils of data sharing, meta-analyses, and estimating cardiovascular risk
Eur Heart J Cardiovasc Pharmacother, 7 (3), e55-e57
DOI 10.1093/ehjcvp/pvaa109, PubMed 32941601
Characteristics, treatment patterns, and residual cardiovascular risk of patients with a first acute myocardial infarction: A nationwide population-based cohort study in Norway
Fundam Clin Pharmacol, 36 (3), 563-571
DOI 10.1111/fcp.12744, PubMed 34904750
Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation - results from the GARFIELD-AF registry
Ann Med, 53 (1), 485-494
DOI 10.1080/07853890.2021.1893897, PubMed 33818226
Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data
BMJ, 375, e066450
DOI 10.1136/bmj-2021-066450, PubMed 34706884
The debated issue of direct oral anticoagulants correct dosing: When even the reviewer is confused
Eur J Intern Med, 90, 125-126
DOI 10.1016/j.ejim.2021.05.009, PubMed 34090747
Modulating the Intensity of Oral Anticoagulation Therapy with Direct Oral Anticoagulants: Feasible or Not?
Am J Cardiovasc Drugs, 22 (2), 113-115
DOI 10.1007/s40256-021-00488-4, PubMed 34254254
Diagnostic Accuracy and Usability of the ECG247 Smart Heart Sensor Compared to Conventional Holter Technology
J Healthc Eng, 2021, 5230947
DOI 10.1155/2021/5230947, PubMed 34765102
Icons in Cardiology
Cardiology, 146 (6), 667
DOI 10.1159/000519019, PubMed 34412055
Minimizing treatment complexity of combat-related soft tissue injuries using a dedicated tension relief system and negative pressure therapy augmented by high-dose in situ antibiotic therapy and oxygen delivery: a retrospective study
Burns Trauma, 9, tkab007
DOI 10.1093/burnst/tkab007, PubMed 34212059
Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials
Heart Fail Rev, 26 (6), 1421-1435
DOI 10.1007/s10741-020-09954-8, PubMed 32314085
Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis
Clin Res Cardiol, 111 (4), 428-439
DOI 10.1007/s00392-021-01913-z, PubMed 34498169
Publications 2020
The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events
Europace, 22 (2), 195-204
DOI 10.1093/europace/euz292, PubMed 31747004
GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke
Future Cardiol, 17 (1), 19-38
DOI 10.2217/fca-2020-0014, PubMed 32696663
Inferior ST-Elevation Myocardial Infarction Presenting When Urgent Primary Percutaneous Coronary Intervention Is Unavailable: Should We Adhere to Current Guidelines?
Cardiovasc Drugs Ther, 34 (6), 865-870
DOI 10.1007/s10557-020-07039-0, PubMed 32671603
Prevalence of genetically verified familial hypercholesterolemia among young (<45 years) Norwegian patients hospitalized with acute myocardial infarction
J Clin Lipidol, 14 (3), 339-345
DOI 10.1016/j.jacl.2020.04.002, PubMed 32418822
Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage : Kinetic profile, relationship to interleukin 6 and infarct size
Eur Heart J Acute Cardiovasc Care, 9 (4), 302-312
DOI 10.1177/2048872620923641, PubMed 32403934
Relative Efficacy of Spironolactone, Eplerenone, and cAnRenone in patients with Chronic Heart failure (RESEARCH): a systematic review and network meta-analysis of randomized controlled trials
Heart Fail Rev, 25 (2), 161-171
DOI 10.1007/s10741-019-09832-y, PubMed 31364027
Pre-hospital One-Hour Troponin in a Low-Prevalence Population of Acute Coronary Syndrome: OUT-ACS study
Open Heart, 7 (2)
DOI 10.1136/openhrt-2020-001296, PubMed 32719074
Cardioversion Safety - Are We Doing Enough?
Cardiology, 145 (11), 740-745
DOI 10.1159/000509343, PubMed 32898849
Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial
Trials, 21 (1), 415
DOI 10.1186/s13063-020-4214-6, PubMed 32446298
Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and design
Am Heart J, 231, 96-104
DOI 10.1016/j.ahj.2020.10.059, PubMed 33203618
Intensification of antithrombotic therapy for chronic atherosclerosis
Tidsskr Nor Laegeforen, 140 (10)
DOI 10.4045/tidsskr.20.0066, PubMed 32602309
Intensification of antithrombotic therapy for chronic atherosclerosis
Tidsskr. Nor. Laegeforen., 140 (10), 976-977
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases
Eur Heart J Cardiovasc Pharmacother, 6 (2), 86-93
DOI 10.1093/ehjcvp/pvz036, PubMed 31392312
Worst lead ST deviation and resolution of ST elevation at one hour for prediction of myocardial salvage, infarct size, and microvascular obstruction in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention
Ann Noninvasive Electrocardiol, 25 (6), e12784
DOI 10.1111/anec.12784, PubMed 32592427
Biomarkers Associated with Atrial Fibrillation in Patients with Ischemic Stroke: A Pilot Study from the NOR-FIB Study
Cerebrovasc Dis Extra, 10 (1), 11-20
DOI 10.1159/000504529, PubMed 32028277
The cancer patient and cardiology
Eur J Heart Fail, 22 (12), 2290-2309
DOI 10.1002/ejhf.1985, PubMed 32809231
Do ACE inhibitors and angiotensin receptor antagonists increase the risk of severe Covid-19?
Tidsskr. Nor. Laegeforen., 140 (9), 859-860
Do ACE inhibitors and angiotensin receptor antagonists increase the risk of severe COVID-19?
Tidsskr Nor Laegeforen, 140 (9)
DOI 10.4045/tidsskr.20.0411, PubMed 32549022
Self-Care Monitoring of Heart Failure Symptoms and Lung Impedance at Home Following Hospital Discharge: Longitudinal Study
J Med Internet Res, 22 (1), e15445
DOI 10.2196/15445, PubMed 31909717
Publications 2019
Pathophysiology, Diagnosis, and Management of the No-Reflow Phenomenon
Cardiovasc Drugs Ther, 33 (5), 589-597
DOI 10.1007/s10557-019-06901-0, PubMed 31418141
Editor's Note
Cardiology, 142 (1), 1
DOI 10.1159/000497089, PubMed 30852568
On-label reduced doses of non-vitamin K anticoagulants prove safe and efficient; yet how to ensure the correct dose for the right patient?
Eur Heart J, 40 (19), 1501-1503
DOI 10.1093/eurheartj/ehz014, PubMed 30753396
Atrial Fibrillation and Stroke in Patients with Hypertrophic Cardiomyopathy: Important New Insights
Thromb Haemost, 119 (3), 355-357
DOI 10.1055/s-0039-1678724, PubMed 30759487
Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis
Eur Heart J Cardiovasc Pharmacother, 5 (1), 12-20
DOI 10.1093/ehjcvp/pvy034, PubMed 30192930
The myth of 'stable' coronary artery disease
Nat Rev Cardiol, 17 (1), 9-21
DOI 10.1038/s41569-019-0233-y, PubMed 31358978
Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe
Heart, 105 (16), 1252-1259
DOI 10.1136/heartjnl-2018-314256, PubMed 30792238
Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction
Am Heart J, 215, 83-90
DOI 10.1016/j.ahj.2019.06.004, PubMed 31291604
Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight
Circulation, 139 (20), 2292-2300
DOI 10.1161/CIRCULATIONAHA.118.037955, PubMed 30773022
Angiotensin receptor neprilysin inhibition for the treatment of hypertension: the neglected child in cardiovascular pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 5 (2), 122-123
DOI 10.1093/ehjcvp/pvz005, PubMed 30698668
B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary disease
BMC Med, 17 (1), 72
DOI 10.1186/s12916-019-1306-9, PubMed 30943979
Does Ivabradine Decrease Cardiovascular Deaths in Heart Failure Patients?
Am J Med, 133 (3), 347-351
DOI 10.1016/j.amjmed.2019.07.046, PubMed 31442391
Ivabradine for heart failure: regulatory differences in Europe and United States
Eur Heart J Cardiovasc Pharmacother, 5 (2), 119-121
DOI 10.1093/ehjcvp/pvz006, PubMed 30715322
Challenging Anticoagulation in Advanced Renal Failure
Am J Med, 132 (11), 1258-1259
DOI 10.1016/j.amjmed.2019.07.002, PubMed 31356767
Gender but not diabetes, hypertension or smoking affects infarct evolution in ST-elevation myocardial infarction patients - data from the CHILL-MI, MITOCARE and SOCCER trials
BMC Cardiovasc Disord, 19 (1), 161
DOI 10.1186/s12872-019-1139-7, PubMed 31269907
Heat Stress Impacts on Cardiac Mortality in Nepali Migrant Workers in Qatar
Cardiology, 143 (1), 37-48
DOI 10.1159/000500853, PubMed 31302648
Atrial fibrillation in cryptogenic stroke and transient ischaemic attack - The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Rationale and design
Eur Stroke J, 4 (2), 172-180
DOI 10.1177/2396987319837089, PubMed 31259265
Mortality and adverse events with brand and generic clopidogrel in the US Food and Drug Administration Adverse Event Reporting System
Eur Heart J Cardiovasc Pharmacother, 5 (4), 210-215
DOI 10.1093/ehjcvp/pvy035, PubMed 30192939
Predicting clinical outcomes after clopidogrel use: easier to postulate than to prove and implement
Pol Arch Intern Med, 129 (2), 78-79
DOI 10.20452/pamw.4467, PubMed 30816102
Gender differences in association between uric acid and all-cause mortality in patients with chronic heart failure
BMC Cardiovasc Disord, 19 (1), 4
DOI 10.1186/s12872-018-0989-8, PubMed 30611196
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke
Eur Heart J Cardiovasc Pharmacother, 5 (3), 171-180
DOI 10.1093/ehjcvp/pvz016, PubMed 31119266
Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1
Eur Heart J, 40 (36), 3010-3012
DOI 10.1093/eurheartj/ehz650, PubMed 31541549
Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis
Int J Cardiol, 289, 83-90
DOI 10.1016/j.ijcard.2019.01.109, PubMed 30827731
Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF
Am J Med, 132 (12), 1431-1440.e7
DOI 10.1016/j.amjmed.2019.06.008, PubMed 31306621
All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System
Am J Ther, 26 (6), e671-e678
DOI 10.1097/MJT.0000000000000883, PubMed 31145139
Health Care Professionals' Perceptions of Home Telemonitoring in Heart Failure Care: Cross-Sectional Survey
J Med Internet Res, 21 (2), e10362
DOI 10.2196/10362, PubMed 30724744
Publications 2018
Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction?
J Cardiovasc Pharmacol Ther, 24 (3), 215-224
DOI 10.1177/1074248418812167, PubMed 30563349
The significance of ST-elevation in aVL in anterolateral myocardial infarction: An assessment by cardiac magnetic resonance imaging
Ann Noninvasive Electrocardiol, 23 (6), e12580
DOI 10.1111/anec.12580, PubMed 29971868
Correlation of anteroseptal ST elevation with myocardial infarction territories through cardiovascular magnetic resonance imaging
J Electrocardiol, 51 (4), 563-568
DOI 10.1016/j.jelectrocard.2018.03.016, PubMed 29996989
Mechanisms of action and clinical use of specific reversal agents for non-vitamin K antagonist oral anticoagulants
Scand Cardiovasc J, 52 (3), 156-162
DOI 10.1080/14017431.2018.1453613, PubMed 29569500
How does the TRS 2°P score relate to real-world patients?
Eur Heart J Cardiovasc Pharmacother, 4 (2), 72-74
DOI 10.1093/ehjcvp/pvy004, PubMed 29554293
Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study
Eur Heart J Cardiovasc Pharmacother, 4 (2), 82-92
DOI 10.1093/ehjcvp/pvx013, PubMed 28475676
Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction
Int J Cardiol, 272, 260-266
DOI 10.1016/j.ijcard.2018.07.137, PubMed 30144995
Correlation of ST changes in leads V4-V6 to area of ischemia by CMR in inferior STEMI
Scand Cardiovasc J, 52 (4), 189-195
DOI 10.1080/14017431.2018.1458145, PubMed 29595340
Cardiac Magnetic Resonance Evaluation of the Extent of Myocardial Injury in Patients with Inferior ST Elevation Myocardial Infarction and Concomitant ST Depression in Leads V1-V3: Analysis from the MITOCARE Study
Cardiology, 140 (3), 178-185
DOI 10.1159/000491745, PubMed 30099440
Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference
Europace, 20 (3), 395-407
DOI 10.1093/europace/eux318, PubMed 29300976
Peripheral arterial disease and limb salvage: a new arena for the cardiologist
Eur Heart J Cardiovasc Pharmacother, 4 (3), 136-137
DOI 10.1093/ehjcvp/pvy014, PubMed 30052851
BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study
Am Heart J, 208, 37-46
DOI 10.1016/j.ahj.2018.10.005, PubMed 30530121
The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions
Heart Fail Rev, 23 (3), 303-323
DOI 10.1007/s10741-018-9685-0, PubMed 29516230
Response to the editor
Heart Fail Rev (in press)
DOI 10.1007/s10741-018-9723-y, PubMed 29968222
Author's response to: letter to the editor
Heart Fail Rev, 23 (5), 819
DOI 10.1007/s10741-018-9728-6, PubMed 30043131
Longitudinal left ventricular function is globally depressed within a week of STEMI
Clin Physiol Funct Imaging, 38 (6), 1029-1037
DOI 10.1111/cpf.12521, PubMed 29701310
In Current Clinical Practice, after Percutaneous Coronary Intervention for Acute Myocardial Infarction, Are β-Blockers Prescribed for Heart Failure or as Secondary Prevention? A Pilot Study
Cardiology, 140 (3), 152-154
DOI 10.1159/000490656, PubMed 30089282
Serum concentration measurements of DOAK drugs Reply
Tidsskr. Nor. Laegeforen., 138 (7), 621
[Antidote treatment during use of direct anticoagulants]
Tidsskr Nor Laegeforen, 138 (3)
DOI 10.4045/tidsskr.17.0190, PubMed 29411596
[Not Available]
Tidsskr Nor Laegeforen, 138 (7)
DOI 10.4045/tidsskr.18.0238, PubMed 29663755
Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial
Circ Heart Fail, 11 (7), e004962
DOI 10.1161/CIRCHEARTFAILURE.118.004962, PubMed 29980595
[Fourth universal definition of myocardial infarction (2018)]
Kardiol Pol, 76 (10), 1383-1415
DOI 10.5603/KP.2018.0203, PubMed 30338834
Increases in Circulating Cardiac Troponin Are Not Always Associated with Myocardial Cell Death
Clin Lab, 64 (11)
DOI 10.7754/Clin.Lab.2018.180615, PubMed 30549980
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry
Eur Heart J, 39 (6), 464-473
DOI 10.1093/eurheartj/ehx730, PubMed 29281086
Publications 2017
ESC working group position paper on myocardial infarction with non-obstructive coronary arteries
Eur Heart J, 38 (3), 143-153
DOI 10.1093/eurheartj/ehw149, PubMed 28158518
Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiative
Int J Cardiol, 249, 274-281
DOI 10.1016/j.ijcard.2017.09.182, PubMed 28964557
Appropriateness of anteroseptal myocardial infarction nomenclature evaluated by late gadolinium enhancement cardiovascular magnetic resonance imaging
J Electrocardiol, 51 (2), 218-223
DOI 10.1016/j.jelectrocard.2017.09.013, PubMed 29103621
European Heart Journal-Cardiovascular Pharmacotherapy in 2016: entering a new level of international recognition
Eur Heart J Cardiovasc Pharmacother, 3 (1), 3-4
DOI 10.1093/ehjcvp/pvw024, PubMed 28062654
[Not Available]
Tidsskr Nor Laegeforen, 137 (6), 424
DOI 10.4045/tidsskr.17.0184, PubMed 28332787
[Not Available]
Tidsskr Nor Laegeforen, 137 (23-24)
DOI 10.4045/tidsskr.17.0967, PubMed 29231634
"False positive troponin values" are not found
Tidsskr. Nor. Laegeforen., 137 (23-24), 1859
Type 2 Diabetes and Heart Failure - More Scrutiny Wanted!
Cardiology, 139 (1), 37-39
DOI 10.1159/000484345, PubMed 29186706
Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase Proteins
Cardiology, 138 (2), 122-132
DOI 10.1159/000475460, PubMed 28651249
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials
Int J Cardiol, 244, 59-66
DOI 10.1016/j.ijcard.2017.06.040, PubMed 28634037
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention
Data Brief, 14, 197-205
DOI 10.1016/j.dib.2017.07.033, PubMed 28795098
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1
Eur Heart J, 38 (12), 852-859
DOI 10.1093/eurheartj/ehv643, PubMed 26848149
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2
Eur Heart J, 38 (12), 860-868
DOI 10.1093/eurheartj/ehw069, PubMed 26848150
Electrocardiographic scores of severity and acuteness of myocardial ischemia predict myocardial salvage in patients with anterior ST-segment elevation myocardial infarction
J Electrocardiol, 51 (2), 195-202
DOI 10.1016/j.jelectrocard.2017.11.002, PubMed 29174706
Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure
Int J Cardiol, 238, 97-104
DOI 10.1016/j.ijcard.2017.03.028, PubMed 28342630
Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure
Clin Res Cardiol, 106 (9), 711-721
DOI 10.1007/s00392-017-1115-0, PubMed 28434020
Patient engagement
Eur Heart J, 38 (42), 3114-3115
DOI 10.1093/eurheartj/ehx600, PubMed 29121227
Impact of climate and air pollution on acute coronary syndromes: an update from the European Society of Cardiology Congress 2017
Scand Cardiovasc J, 52 (1), 1-3
DOI 10.1080/14017431.2017.1405069, PubMed 29202608
2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS
Rev Esp Cardiol (Engl Ed), 70 (1), 50
DOI 10.1016/j.rec.2016.11.033, PubMed 28038729
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis
Eur Heart J, 38 (22), 1710-1716
DOI 10.1093/eurheartj/ehv676, PubMed 26705385
Changes in oral anticoagulation for elective cardioversion: results from a European cardioversion registry
Eur Heart J Cardiovasc Pharmacother, 3 (3), 147-150
DOI 10.1093/ehjcvp/pvx003, PubMed 28329309
Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial
Am J Med, 131 (3), 269-275.e2
DOI 10.1016/j.amjmed.2017.10.036, PubMed 29122636
Time-resolved tracking of the atrioventricular plane displacement in Cardiovascular Magnetic Resonance (CMR) images
BMC Med Imaging, 17 (1), 19
DOI 10.1186/s12880-017-0189-5, PubMed 28241751
Myocardium at risk assessed by electrocardiographic scores and cardiovascular magnetic resonance - a MITOCARE substudy
J Electrocardiol, 50 (6), 725-731
DOI 10.1016/j.jelectrocard.2017.08.019, PubMed 28918213
Spironolactone Treatment and Effect on Survival in Chronic Heart Failure Patients with Reduced Renal Function: A Propensity-Matched Study
Cardiorenal Med, 7 (2), 128-136
DOI 10.1159/000454933, PubMed 28611786
Gender differences in the effects of cardiovascular drugs
Eur Heart J Cardiovasc Pharmacother, 3 (3), 163-182
DOI 10.1093/ehjcvp/pvw042, PubMed 28329228
Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin
Stroke, 48 (12), 3266-3273
DOI 10.1161/STROKEAHA.117.017574, PubMed 29089455
Neurohormonal Blockade in Heart Failure
Card Fail Rev, 3 (1), 19-24
DOI 10.15420/cfr.2016:22:2, PubMed 28785471
Publications 2016
Cardiovascular pharmacotherapy
Int J Cardiol, 224, 412-415
DOI 10.1016/j.ijcard.2016.09.065, PubMed 27690338
Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489]
Eur J Heart Fail, 18 (6), 727
DOI 10.1002/ejhf.591, PubMed 27324688
Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency
Eur J Heart Fail, 18 (5), 482-9
DOI 10.1002/ejhf.516, PubMed 27071916
'Ten Commandments' of 2016 ESC Guidelines for the management of atrial fibrillation
Eur Heart J, 37 (38), 2853
DOI 10.1093/eurheartj/ehw370, PubMed 27923817
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
Heart, 103 (4), 307-314
DOI 10.1136/heartjnl-2016-309832, PubMed 27647168
Sample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as Endpoint
J Am Heart Assoc, 5 (3), e002708
DOI 10.1161/JAHA.115.002708, PubMed 26961520
A new automatic algorithm for quantification of myocardial infarction imaged by late gadolinium enhancement cardiovascular magnetic resonance: experimental validation and comparison to expert delineations in multi-center, multi-vendor patient data
J Cardiovasc Magn Reson, 18 (1), 27
DOI 10.1186/s12968-016-0242-5, PubMed 27145749
Assessment of Right Ventricular Afterload in COPD
COPD, 13 (2), 176-85
DOI 10.3109/15412555.2015.1057275, PubMed 26914261
New anticoagulants in combination with antiplatelet agents
Tidsskr Nor Laegeforen, 136 (18), 1543-1546
DOI 10.4045/tidsskr.15.1356, PubMed 27731598
[2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS]
Kardiol Pol, 74 (12), 1359-1469
DOI 10.5603/KP.2016.0172, PubMed 28009037
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Europace, 18 (11), 1609-1678
DOI 10.1093/europace/euw295, PubMed 27567465
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Eur J Cardiothorac Surg, 50 (5), e1-e88
DOI 10.1093/ejcts/ezw313, PubMed 27663299
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Eur Heart J, 37 (38), 2893-2962
DOI 10.1093/eurheartj/ehw210, PubMed 27567408
Extent of Myocardium at Risk for Left Anterior Descending Artery, Right Coronary Artery, and Left Circumflex Artery Occlusion Depicted by Contrast-Enhanced Steady State Free Precession and T2-Weighted Short Tau Inversion Recovery Magnetic Resonance Imaging
Circ Cardiovasc Imaging, 9 (7)
DOI 10.1161/CIRCIMAGING.115.004376, PubMed 27412659
Multi-vendor, multicentre comparison of contrast-enhanced SSFP and T2-STIR CMR for determining myocardium at risk in ST-elevation myocardial infarction
Eur Heart J Cardiovasc Imaging, 17 (7), 744-53
DOI 10.1093/ehjci/jew027, PubMed 27002140
Automatic segmentation of myocardium at risk from contrast enhanced SSFP CMR: validation against expert readers and SPECT
BMC Med Imaging, 16, 19
DOI 10.1186/s12880-016-0124-1, PubMed 26946139
In memoriam Henry Krum, 1958-2015
Cardiology, 134 (2), 107-8
DOI 10.1159/000444294, PubMed 26950607
Cost-effectiveness of antiplatelet drugs after percutaneous coronary intervention
Eur Heart J Qual Care Clin Outcomes, 2 (1), 52-57
DOI 10.1093/ehjqcco/qcv023, PubMed 29474586
Publications 2015
The National Cardiac Societies of the European Society of Cardiology
Eur Heart J, 36 (21), 1278
DOI 10.1093/eurheartj/ehv091, PubMed 26034059
Morphine in myocardial infarction: balancing on the tight rope
Eur Heart J, 37 (3), 253-5
DOI 10.1093/eurheartj/ehv546, PubMed 26491111
End of story? Studies on prevention of reperfusion injury encounter perpetual defeats
Eur Heart J Cardiovasc Pharmacother, 1 (1), 46-7
DOI 10.1093/ehjcvp/pvu018, PubMed 27533965
Expanding the Evidence Base: Comparing Randomized Controlled Trials and Observational Studies of Statins
Am J Ther, 22 (5), e141-50
DOI 10.1097/MJT.0b013e318245ce94, PubMed 22487773
ESC guidelines adherence is associated with improved survival in patients from the Norwegian Heart Failure Registry
Eur Heart J Cardiovasc Pharmacother, 1 (1), 31-6
DOI 10.1093/ehjcvp/pvu010, PubMed 27533962
The Effects of Climate Change on Cardiac Health
Cardiology, 131 (4), 209-17
DOI 10.1159/000398787, PubMed 25997478
Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial
Eur Heart J Cardiovasc Pharmacother, 1 (2), 86-94
DOI 10.1093/ehjcvp/pvu024, PubMed 27533976
Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure: Carvedilol or Metoprolol Evaluation Study
Circ Heart Fail, 8 (5), 887-96
DOI 10.1161/CIRCHEARTFAILURE.114.001701, PubMed 26175538
Cauda Equina Syndrome in a 36 Week Gravida Patient
Isr Med Assoc J, 17 (8), 522-3
PubMed 26394499
Increased LV apical untwist during preload reduction in healthy humans: an echocardiographic speckle tracking study during lower body negative pressure
Physiol Rep, 3 (3)
DOI 10.14814/phy2.12330, PubMed 25802362
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology
Eur Heart J, 37 (9), 747-54
DOI 10.1093/eurheartj/ehv213, PubMed 26077039
Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome
Heart, 101 (18), 1475-84
DOI 10.1136/heartjnl-2014-307346, PubMed 26109589
Non-vitamin K oral anticoagulants in 'valvular' atrial fibrillation: a call for action
Europace, 18 (1), 1-3
DOI 10.1093/europace/euv318, PubMed 26462701
Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial
Eur Heart J, 36 (33), 2239-45
DOI 10.1093/eurheartj/ehv201, PubMed 25971288
Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial
Eur Heart J, 36 (46), 3268-75
DOI 10.1093/eurheartj/ehv447, PubMed 26371113
Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative
Eur J Heart Fail, 17 (11), 1144-51
DOI 10.1002/ejhf.419, PubMed 26424212
Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis
Int J Cardiol, 186, 104-5
DOI 10.1016/j.ijcard.2015.03.116, PubMed 25828104
Publications 2014
Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results
Eur Heart J, 36 (2), 112-9
DOI 10.1093/eurheartj/ehu331, PubMed 25179768
Anticoagulants for secondary prevention after acute myocardial infarction: lessons from the past decade
Fundam Clin Pharmacol, 28 (4), 353-63
DOI 10.1111/fcp.12063, PubMed 24494730
Calcaneocuboid arthrodesis for recurrent clubfeet: what is the outcome at 17-year follow-up?
J Child Orthop, 8 (1), 43-8
DOI 10.1007/s11832-014-0557-4, PubMed 24504417
The association between meteorological events and acute heart failure: new insights from ASCEND-HF
Int J Cardiol, 177 (3), 819-24
DOI 10.1016/j.ijcard.2014.11.066, PubMed 25465826
Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
Am Heart J, 169 (2), 257-265.e1
DOI 10.1016/j.ahj.2014.10.015, PubMed 25641535
Myeloid-related protein-8/14 and C-reactive protein in individuals evaluated for obstructive sleep apnea
Sleep Med, 15 (7), 762-8
DOI 10.1016/j.sleep.2014.03.008, PubMed 24841106
Effects of FX06 in vitro on platelet, coagulation, and fibrinolytic biomarkers in volunteers and patients with documented coronary artery disease
Am J Ther, 21 (2), 91-8
DOI 10.1097/MJT.0b013e3181b0a6ff, PubMed 19770797
Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
Eur Heart J, 35 (28), 1864-72
DOI 10.1093/eurheartj/ehu046, PubMed 24561548
Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy
Clin Chem, 61 (2), 368-78
DOI 10.1373/clinchem.2014.226936, PubMed 25451868
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial
Eur Heart J, 35 (37), 2516-23
DOI 10.1093/eurheartj/ehu177, PubMed 24796339
Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
Europace, 17 (2), 194-206
DOI 10.1093/europace/euu201, PubMed 25149078
Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction
J Am Coll Cardiol, 64 (21), 2281-93
DOI 10.1016/j.jacc.2014.08.036, PubMed 25456761
Fatal sepsis and systemic inflammatory response syndrome after off-label prasugrel: a case report
Am J Ther, 21 (6), e229-33
DOI 10.1097/MJT.0b013e31828fdb1c, PubMed 23665886
Effect of aliskiren and valsartan combination versus aliskiren monotherapy on hemostatic biomarkers in hypertensive diabetics: Aliskiren and Valsartan Impact in Diabetics pilot trial
Am J Ther, 21 (6), 482-90
DOI 10.1097/MJT.0b013e31826915ab, PubMed 23698186
Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients
JACC Cardiovasc Imaging, 7 (9), 930-9
DOI 10.1016/j.jcmg.2014.05.010, PubMed 25212799
Comorbidities and polypharmacy
Heart Fail Clin, 10 (2), 367-72
DOI 10.1016/j.hfc.2013.12.001, PubMed 24656112
Current role of neprilysin inhibitors in hypertension and heart failure
Pharmacol Ther, 144 (1), 41-9
DOI 10.1016/j.pharmthera.2014.05.002, PubMed 24836726
Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy
Circ Heart Fail, 8 (1), 71-8
DOI 10.1161/CIRCHEARTFAILURE.114.001785, PubMed 25362207
Publications 2013
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy
Eur Heart J, 34 (23), 1708-13, 1713a-1713b
DOI 10.1093/eurheartj/eht042, PubMed 23425521
Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial
Eur Heart J, 35 (4), 224-32
DOI 10.1093/eurheartj/eht445, PubMed 24144788
'Patient choice' concept in AF ESC Guidelines: is the clinician giving up? Reply
Europace, 15 (3), 460-1
DOI 10.1093/europace/eus386, PubMed 23430752
Questionable levels of evidence in new atrial fibrillation guidelines? Reply
Europace, 15 (3), 461-2
DOI 10.1093/europace/eus394, PubMed 23430753
Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study
Eur J Clin Pharmacol, 69 (10), 1747-55
DOI 10.1007/s00228-013-1512-x, PubMed 23743778
New oral anticoagulants--a review
Tidsskr Nor Laegeforen, 133 (18), 1940-5
DOI 10.4045/tidsskr.12.1111, PubMed 24084970
Obstructive sleep apnea: no independent association to troponins
Sleep Breath, 18 (2), 351-8
DOI 10.1007/s11325-013-0892-6, PubMed 24043484
High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
Circulation, 129 (6), 625-34
DOI 10.1161/CIRCULATIONAHA.113.006286, PubMed 24226808
High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin
J Am Coll Cardiol, 63 (1), 52-61
DOI 10.1016/j.jacc.2013.07.093, PubMed 24055845
Matrix metalloproteinases and the activity of their tissue inhibitors in patients with ST-elevation myocardial infarction treated with primary angioplasty
Kardiol Pol, 71 (5), 453-63
DOI 10.5603/KP.2013.0091, PubMed 23788085
A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
Europace, 16 (3), 308-19
DOI 10.1093/europace/eut373, PubMed 24351881
Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes
Int J Cardiol, 168 (3), 2510-7
DOI 10.1016/j.ijcard.2013.03.037, PubMed 23578889
Prasugrel: the real-life perspective
Circ Cardiovasc Qual Outcomes, 6 (3), 253-4
DOI 10.1161/CIRCOUTCOMES.113.000239, PubMed 23674315
Oxygen therapy in acute coronary syndrome: are the benefits worth the risk?
Eur Heart J, 34 (22), 1630-5
DOI 10.1093/eurheartj/eht110, PubMed 23554440
Diuretic use in heart failure and outcomes
Clin Pharmacol Ther, 94 (4), 490-8
DOI 10.1038/clpt.2013.140, PubMed 23852396
Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure
Circ Heart Fail, 6 (3), 594-605
DOI 10.1161/CIRCHEARTFAILURE.112.000289, PubMed 23694773
Cost effectiveness of drug-eluting stents as compared with bare metal stents in patients with coronary artery disease
Am J Ther, 20 (6), 596-601
DOI 10.1097/MJT.0b013e3182211a01, PubMed 21822114
[Atrial fibrillation and stroke]
Tidsskr Nor Laegeforen, 133 (14), 1453-7
DOI 10.4045/tidsskr.12.0850, PubMed 23929293
Publications 2012
Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study
Am J Hypertens, 25 (6), 644-50
DOI 10.1038/ajh.2012.12, PubMed 22378036
The L-arginine/asymmetric dimethylarginine ratio is improved by anti-tumor necrosis factor-α therapy in inflammatory arthropathies. Associations with aortic stiffness
Atherosclerosis, 225 (1), 160-5
DOI 10.1016/j.atherosclerosis.2012.08.033, PubMed 23014354
[How to diagnose a heart attack in 2012?]
Tidsskr Nor Laegeforen, 132 (3), 265-6
DOI 10.4045/tidsskr.11.1367, PubMed 22314724
Conclusion
Adv Cardiol, 47, 165
DOI 10.1159/000341140, PubMed 22906911
Antiplatelet Therapy in ACS and A-Fib Conclusion
Adv.Cardiol., 47, 165
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association
Eur Heart J, 33 (21), 2719-47
DOI 10.1093/eurheartj/ehs253, PubMed 22922413
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association
Europace, 14 (10), 1385-413
DOI 10.1093/europace/eus305, PubMed 22923145
Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study
Eur J Heart Fail, 14 (11), 1257-64
DOI 10.1093/eurjhf/hfs110, PubMed 22764184
Changes in diagnosing non-ST-segment elevation myocardial infarction after the introduction of a new high-sensitivity cardiac troponin T assay: a single-centre experience
Clin Lab, 58 (9-10), 1029-36
DOI 10.7754/Clin.Lab.2012.111206, PubMed 23163120
Pharmacological conversion of recent-onset atrial fibrillation: a systematic review
Scand Cardiovasc J Suppl, 47 (1), 2-10
DOI 10.3109/14017431.2012.740572, PubMed 23067130
Regional LV deformation in healthy individuals during isovolumetric contraction and ejection phases assessed by 2D speckle tracking echocardiography
Clin Physiol Funct Imaging, 32 (5), 372-9
DOI 10.1111/j.1475-097X.2012.01139.x, PubMed 22856344
Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF
Eur J Heart Fail, 15 (4), 456-64
DOI 10.1093/eurjhf/hfs188, PubMed 23159547
Viewpoint: Central adjudication of myocardial infarction in outcome-driven clinical trials--common patterns in TRITON, RECORD, and PLATO?
Thromb Haemost, 108 (3), 412-4
DOI 10.1160/TH12-04-0251, PubMed 22836596
Introduction. Antiplatelet therapy in ACS and A-Fib
Adv Cardiol, 47, 1-4
DOI 10.1159/000338206, PubMed 22906898
Antiplatelet Therapy in ACS and A-Fib Introduction
Adv.Cardiol., 47, 1-4
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
Eur Heart J, 33 (20), 2569-619
DOI 10.1093/eurheartj/ehs215, PubMed 22922416
Third universal definition of myocardial infarction
Circulation, 126 (16), 2020-35
DOI 10.1161/CIR.0b013e31826e1058, PubMed 22923432
Third universal definition of myocardial infarction
J Am Coll Cardiol, 60 (16), 1581-98
DOI 10.1016/j.jacc.2012.08.001, PubMed 22958960
Third universal definition of myocardial infarction
Eur Heart J, 33 (20), 2551-67
DOI 10.1093/eurheartj/ehs184, PubMed 22922414
Publications 2011
[New European guidelines for acute myocardial infarction]
Tidsskr Nor Laegeforen, 131 (23), 2340
DOI 10.4045/tidsskr.11.1133, PubMed 22139110
Apixaban with antiplatelet therapy after acute coronary syndrome
N Engl J Med, 365 (8), 699-708
DOI 10.1056/NEJMoa1105819, PubMed 21780946
Inter-patient variability and impact of proton pump inhibitors on platelet reactivity after prasugrel
Thromb Haemost, 107 (2), 338-45
DOI 10.1160/TH11-09-0622, PubMed 22186910
Intravenous vernakalant: a review of its use in the management of recent-onset atrial fibrillation (vol 71, pg 237, 2011)
Drugs, 71 (3), 381
Dronedarone in high-risk permanent atrial fibrillation
N Engl J Med, 365 (24), 2268-76
DOI 10.1056/NEJMoa1109867, PubMed 22082198
The course of D-dimer, high-sensitivity C-reactive protein and pro-B-type natriuretic peptide in patients with non-ST-elevation myocardial infarction
Clin Lab, 57 (9-10), 771-6
PubMed 22029194
Apixaban versus warfarin in patients with atrial fibrillation
N Engl J Med, 365 (11), 981-92
DOI 10.1056/NEJMoa1107039, PubMed 21870978
A single level of plasma troponin-I predicts left ventricular remodelling after primary angioplasty reply
Heart, 97 (4), 341
DOI 10.1136/hrt.2010.218412
Relation of cardiac troponin I and microvascular obstruction following ST-elevation myocardial infarction
Acute Card Care, 13 (1), 48-51
DOI 10.3109/17482941.2010.538698, PubMed 21244230
Reduced preload elicits increased LV twist in healthy humans: an echocardiographic speckle-tracking study during lower body negative pressure
Clin Physiol Funct Imaging, 31 (5), 382-9
DOI 10.1111/j.1475-097X.2011.01029.x, PubMed 21771258
Fatty Acid binding protein 4 is associated with carotid atherosclerosis and outcome in patients with acute ischemic stroke
PLoS One, 6 (12), e28785
DOI 10.1371/journal.pone.0028785, PubMed 22174896
Troponin I degradation in serum of patients with acute ischemic stroke
Scand J Clin Lab Invest, 71 (1), 74-80
DOI 10.3109/00365513.2010.542485, PubMed 21214502
Increased heart rate variability during nondirective meditation
Eur J Prev Cardiol, 19 (4), 773-80
DOI 10.1177/1741826711414625, PubMed 21693507
Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction
Heart, 98 (1), 31-6
DOI 10.1136/heartjnl-2011-300079, PubMed 21727201
Effect of nesiritide in patients with acute decompensated heart failure
N Engl J Med, 365 (1), 32-43
DOI 10.1056/NEJMoa1100171, PubMed 21732835
Early prediction of increased arterial stiffness in patients with chronic inflammation: a 15-year followup study of 108 patients with rheumatoid arthritis
J Rheumatol, 38 (4), 606-12
DOI 10.3899/jrheum.100689, PubMed 21239744
Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study
Ann Rheum Dis, 70 (5), 812-7
DOI 10.1136/ard.2010.141523, PubMed 21288959
The Diagnostic Value of the Vacuum Phenomenon during Hip Arthroscopy
ISRN Orthop, 2011, 852390
DOI 10.5402/2011/852390, PubMed 24977068
Early impact of prescription Omega-3 fatty acids on platelet biomarkers in patients with coronary artery disease and hypertriglyceridemia
Cardiology, 118 (3), 187-94
DOI 10.1159/000329300, PubMed 21701167
Activated leukocyte cell adhesion molecule and prognosis in acute ischemic stroke
Stroke, 42 (9), 2453-8
DOI 10.1161/STROKEAHA.110.612440, PubMed 21757661
Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology
Eur Heart J, 32 (15), 1854-64
DOI 10.1093/eurheartj/ehr204, PubMed 21715717
Soluble CXCL16 and long-term outcome in acute ischemic stroke
Atherosclerosis, 220 (1), 244-9
DOI 10.1016/j.atherosclerosis.2011.10.004, PubMed 22055341
Amyotrophic lateral sclerosis (ALS), a novel rare cause of elevated plasma troponin T levels
Clin Lab, 57 (7-8), 615-8
PubMed 21888026
Publications 2010
Changes in arterial stiffness during continued infliximab treatment in patients with inflammatory arthropathies
Fundam Clin Pharmacol, 25 (4), 511-7
DOI 10.1111/j.1472-8206.2010.00872.x, PubMed 20825487
Should oxygen be given in myocardial infarction?
BMJ, 340, c3287
DOI 10.1136/bmj.c3287, PubMed 20558515
Oxygen in myocardial infarction Author's reply
BMJ-British Medical Journal, 341, c3717
DOI 10.1136/bmj.c3717
'Treat to target': moving targets from hypertension, hyperlipidaemia and diabetes to rheumatoid arthritis
Ann Rheum Dis, 69 (4), 629-30
DOI 10.1136/ard.2010.128462, PubMed 20237122
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
Europace, 12 (10), 1360-420
DOI 10.1093/europace/euq350, PubMed 20876603
COPD predicts mortality in HF: the Norwegian Heart Failure Registry
J Card Fail, 16 (3), 225-9
DOI 10.1016/j.cardfail.2009.12.002, PubMed 20206897
The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology
Rev. Port. Cardiol., 29 (4), 633-699
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
Eur Heart J, 31 (19), 2369-429
DOI 10.1093/eurheartj/ehq278, PubMed 20802247
Maximizing scientific knowledge from randomized clinical trials
Am Heart J, 159 (6), 937-43
DOI 10.1016/j.ahj.2010.03.002, PubMed 20569703
A window into your heart: taking cardiac troponin to the next level
Biomark Med, 4 (6), 889-94
DOI 10.2217/bmm.10.103, PubMed 21133709
Optimal time-point of ST-segment assessment for risk-stratification following primary percutaneous coronary intervention
Am J Cardiol, 105 (11), 1648-9; author reply 1649-50
DOI 10.1016/j.amjcard.2010.03.006, PubMed 20494681
Cardiac troponin I for the prediction of functional recovery and left ventricular remodelling following primary percutaneous coronary intervention for ST-elevation myocardial infarction
Heart, 96 (23), 1892-7
DOI 10.1136/hrt.2009.190819, PubMed 21062778
Determinants and prognostic implications of cardiac troponin T measured by a sensitive assay in type 2 diabetes mellitus
Cardiovasc Diabetol, 9, 52
DOI 10.1186/1475-2840-9-52, PubMed 20843304
Incremental value of a combination of cardiac troponin T, N-terminal pro-brain natriuretic peptide and C-reactive protein for prediction of mortality in end-stage renal disease
Scand J Urol Nephrol, 45 (2), 151-8
DOI 10.3109/00365599.2010.529819, PubMed 21091090
Impact of time to therapy and presence of collaterals on the efficacy of FX06 in acute ST elevation myocardial infarction: a substudy of the F.I.R.E., the Efficacy of FX06 in the prevention of myocardial reperfusion injury trial
EuroIntervention, 5 (8), 946-52
DOI 10.4244/EIJV5I8A159, PubMed 20542780
Influence of ST-segment recovery on infarct size and ejection fraction in patients with ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention
Am J Cardiol, 105 (9), 1223-8
DOI 10.1016/j.amjcard.2009.12.034, PubMed 20403470
Sudden cardiac death--the challenge to cardiology
Fundam Clin Pharmacol, 24 (5), 535-7
DOI 10.1111/j.1472-8206.2010.00875_3.x, PubMed 20854303
NT-proBNP predicts mortality in patients with rheumatoid arthritis: results from 10-year follow-up of the EURIDISS study
Ann Rheum Dis, 69 (11), 1946-50
DOI 10.1136/ard.2009.127704, PubMed 20525846
Androgenic anabolic steroid abuse and the cardiovascular system
Handb Exp Pharmacol (195), 411-57
DOI 10.1007/978-3-540-79088-4_18, PubMed 20020375
Publications 2009
Interpreting clinical trials: the 'beautiful' case
Fundam Clin Pharmacol, 23 (2), 261-2
DOI 10.1111/j.1472-8206.2009.00682.x, PubMed 19236485
Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study
Hypertension, 55 (2), 333-8
DOI 10.1161/HYPERTENSIONAHA.109.143982, PubMed 20038753
Hotline sessions of the 30th European Congress of Cardiology
Eur Heart J, 30 (9), 1151
DOI 10.1093/eurheartj/ehp095, PubMed 19339265
Clinical review: impact of statin substitution policies on patient outcomes
Ann Med, 41 (4), 242-56
DOI 10.1080/07853890902729786, PubMed 19191052
Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial
J Am Coll Cardiol, 53 (8), 720-9
DOI 10.1016/j.jacc.2008.12.017, PubMed 19232907
Gender differences among Norwegian patients with heart failure
Int J Cardiol, 146 (3), 354-8
DOI 10.1016/j.ijcard.2009.07.014, PubMed 19700210
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 (vol 29, pg 2388, 2008)
Eur. J. Heart Fail., 11 (1), 110
DOI 10.1093/eurjhf/hfn030
In ST-Elevation myocardial infarction patients receiving primary percutaneous coronary intervention, admission cardiac troponin T and peak cardiac troponin T values differ in their prognostic properties
Am J Cardiol, 103 (9), 1331
DOI 10.1016/j.amjcard.2009.02.032, PubMed 19406285
Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction
Am J Cardiol, 104 (11), 1472-7
DOI 10.1016/j.amjcard.2009.07.019, PubMed 19932777
Usefulness of natriuretic peptide testing for long-term risk assessment following acute ischemic stroke
Am J Cardiol, 104 (2), 287-91
DOI 10.1016/j.amjcard.2009.03.029, PubMed 19576362
Osteoprotegerin concentrations and prognosis in acute ischaemic stroke
J Intern Med, 267 (4), 410-7
DOI 10.1111/j.1365-2796.2009.02163.x, PubMed 19895657
Cardiac troponin I degradation in serum of patients with hypertrophic obstructive cardiomyopathy undergoing percutaneous septal ablation
Cardiology, 114 (3), 167-73
DOI 10.1159/000226596, PubMed 19571537
Association of platelet responsiveness with clopidogrel metabolism: role of compliance in the assessment of "resistance"
Am Heart J, 158 (6), 925-32
DOI 10.1016/j.ahj.2009.10.012, PubMed 19958858
Correlation of inhibition of platelet aggregation after clopidogrel with post discharge bleeding events: assessment by different bleeding classifications
Eur Heart J, 31 (2), 227-35
DOI 10.1093/eurheartj/ehp434, PubMed 19854728
The PLATO trial: do you believe in magic?
Eur Heart J, 31 (7), 764-7
DOI 10.1093/eurheartj/ehp545, PubMed 20007979
Antiplatelet 'resistance' and 'non-responders': what do these terms really mean?
Fundam Clin Pharmacol, 23 (1), 11-8
DOI 10.1111/j.1472-8206.2008.00663.x, PubMed 19267767
Publications 2008
New definition of myocardial infarction
BMJ, 337, a3078
DOI 10.1136/bmj.a3078, PubMed 19109323
[Arthroscopic treatment for osteoarthritic knee]
Harefuah, 147 (4), 330-4, 373
PubMed 18686816
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Eur Heart J, 29 (19), 2388-442
DOI 10.1093/eurheartj/ehn309, PubMed 18799522
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Eur J Heart Fail, 10 (10), 933-89
DOI 10.1016/j.ejheart.2008.08.005, PubMed 18826876
ESC Guidelines for the Diagnosis And Treatment of Acute And Chronic Heart Failure 2008
Rev. Esp. Cardiol., 61 (12), 1329
DOI 10.1016/S1885-5857(09)60059-1
Guidelines 2008 European Society of Cardiology on the diagnosis and treatment of acute and chronic heart failure
Kardiol. Pol., 66 (11 4), S389-S454
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 (vol 29, pg 2388, 2008)
Eur. Heart J., 29 (24), 3069
DOI 10.1093/eurheartj/ehn528
[European practice guidelines on prevention of cardiovascular diseases: executive summary]
G Ital Cardiol (Rome), 9 (1), 11-59
PubMed 18383763
Comparison of four different cardiac troponin assays in patients with end-stage renal disease on chronic haemodialysis
Acute Card Care, 10 (3), 173-80
DOI 10.1080/17482940802100279, PubMed 18608043
New-onset atrial fibrillation in bacteremia is not associated with C-reactive protein, but is an indicator of increased mortality during hospitalization
Cardiology, 111 (3), 171-80
DOI 10.1159/000121600, PubMed 18434721
The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: a 10-year longitudinal study
Arthritis Res Ther, 10 (3), R70
DOI 10.1186/ar2442, PubMed 18573197
Incidence and causes of new-onset dyspnea in 3,719 patients treated with clopidogrel and aspirin combination after coronary stenting
Thromb Haemost, 100 (2), 314-8
DOI 10.1160/TH08-05-0291, PubMed 18690353
Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?
Cerebrovasc Dis, 26 (5), 563-4
DOI 10.1159/000164555, PubMed 18936537
Effects of aliskiren, a renin inhibitor, on biomarkers of platelet activity, coagulation and fibrinolysis in subjects with multiple risk factors for vascular disease
J Hum Hypertens, 22 (5), 303-10
DOI 10.1038/jhh.2008.2, PubMed 18273042
Bleeding risks of combination vs. single antiplatelet therapy: a meta-analysis of 18 randomized trials comprising 129,314 patients
Fundam Clin Pharmacol, 22 (3), 315-21
DOI 10.1111/j.1472-8206.2008.00582.x, PubMed 18485150
Noninvasive coronary angiography with 64-channel multidetector computed tomography in patients with acute coronary syndrome
Acta Radiol, 49 (10), 1140-4
DOI 10.1080/02841850802452083, PubMed 18932101
Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study
J Thromb Thrombolysis, 27 (1), 48-56
DOI 10.1007/s11239-007-0189-3, PubMed 18188512
Publications 2007
Levosimendan: perpetuum mobile?
Eur Heart J, 28 (4), 515
DOI 10.1093/eurheartj/ehl487, PubMed 17283001
A change of scene: Dan Atar, PhD, MD, FESC. Interview by Emma Wilkinson
Circulation, 116 (12), f67-9
DOI 10.1161/CIRCULATIONAHA.107.186286, PubMed 17875974
[Health and health care in Norway]
Ugeskr Laeger, 169 (51), 4445-7
PubMed 18208684
Cholesterol and peripheral vascular disease: a neglected topic?
Scand Cardiovasc J, 41 (3), 136-7
DOI 10.1080/14017430701316581, PubMed 17487760
Antiplatelet properties of escitalopram in patients with the metabolic syndrome: a dose-ranging in vitro study
Neuropsychopharmacology, 32 (11), 2369-74
DOI 10.1038/sj.npp.1301355, PubMed 17356575
European guidelines on cardiovascular disease prevention in clinical practice: executive summary
Atherosclerosis, 194 (1), 1-45
DOI 10.1016/j.atherosclerosis.2007.08.024, PubMed 17880983
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)
Eur J Cardiovasc Prev Rehabil, 14 Suppl 2, E1-40
DOI 10.1097/01.hjr.0000277984.31558.c4, PubMed 17726406
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)
Eur J Cardiovasc Prev Rehabil, 14 Suppl 2, S1-113
DOI 10.1097/01.hjr.0000277983.23934.c9, PubMed 17726407
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)
Eur Heart J, 28 (19), 2375-414
DOI 10.1093/eurheartj/ehm316, PubMed 17726041
Mechanism of troponin elevations in patients with acute ischemic stroke
Am J Cardiol, 99 (6), 867-70
DOI 10.1016/j.amjcard.2006.10.052, PubMed 17350385
Asymptomatic myocardial infarction prior to ischemic stroke?
Cerebrovasc Dis, 24 (2-3), 318
DOI 10.1159/000106519, PubMed 17675837
The relation between electrocardiographic ST-T changes and NT-proBNP in patients with acute ischemic stroke
Scand Cardiovasc J, 41 (5), 294-8
DOI 10.1080/14017430701601644, PubMed 17886116
[Hyperbaric oxygen therapy for chronic diabetic wounds of the lower limbs--a review of the literature]
Harefuah, 146 (3), 223-7, 244-5
PubMed 17460932
N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis
Kidney Int, 71 (6), 548-54
DOI 10.1038/sj.ki.5002087, PubMed 17299526
Evaluation of dyspnoea in a sample of elderly subjects recruited from general practice
Int J Clin Pract, 61 (9), 1481-91
DOI 10.1111/j.1742-1241.2007.01428.x, PubMed 17686092
Fluorimetric quantitation of citalopram and escitalopram in plasma: developing an express method to monitor compliance in clinical trials
Clin Chem Lab Med, 45 (4), 513-20
DOI 10.1515/CCLM.2007.108, PubMed 17439330
Patients with metabolic syndrome exhibit higher platelet activity than those with conventional risk factors for vascular disease
J Thromb Thrombolysis, 25 (2), 207-13
DOI 10.1007/s11239-007-0047-3, PubMed 17530178
Combination antiplatelet therapy with aspirin and clopidogrel: the role of antecedent and concomitant doses of aspirin. An analysis of 711 patients
Cardiology, 107 (4), 307-12
DOI 10.1159/000099067, PubMed 17264511
Consistent platelet inhibition during long-term maintenance-dose clopidogrel therapy among 359 compliant outpatients with documented vascular disease
Am Heart J, 153 (3), 371-7
DOI 10.1016/j.ahj.2006.12.006, PubMed 17307414
Dyspnoea after antiplatelet agents: the AZD6140 controversy
Int J Clin Pract, 61 (3), 529-33
DOI 10.1111/j.1742-1241.2007.01294.x, PubMed 17313629
Dyspnoea after AZD 6140: blaming the messenger
Int. J. Clin. Pract., 61 (9), 1591
DOI 10.1111/j.1742-1241.2007.01398.x
Rheumatic mitral valve stenosis mimicking advanced lung cancer
Heart Vessels, 22 (5), 345-8
DOI 10.1007/s00380-007-0979-8, PubMed 17879027
[Congestive heart failure--etiology and diagnostic procedures]
Tidsskr Nor Laegeforen, 127 (2), 171-3
PubMed 17237863
[Treatment of congestive heart failure]
Tidsskr Nor Laegeforen, 127 (2), 174-7
PubMed 17237864
Publications 2006
Rationale and design of the 'F.I.R.E.' study. A multicenter, double-blind, randomized, placebo-controlled study to measure the effect of FX06 (a fibrin-derived peptide Bbeta(15-42)) on ischemia-reperfusion injury in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
Cardiology, 108 (2), 117-23
DOI 10.1159/000095982, PubMed 17019083
Escitalopram, but not its major metabolites, exhibits antiplatelet activity in humans
J Clin Psychopharmacol, 26 (2), 172-7
DOI 10.1097/01.jcp.0000204047.76286.6e, PubMed 16633147
[Trends and characteristics of diabetes-related lower limb amputations in the Negev, 1996-1999]
Harefuah, 145 (10), 709-12, 784
PubMed 17111702
Pediatric olecranon fractures: open reduction and internal fixation with removable Kirschner wires and absorbable sutures
J Pediatr Orthop, 26 (1), 39-42
DOI 10.1097/01.bpo.0000187988.86892.a2, PubMed 16439899
[Medical and ventilatory treatment of acute heart failure]
Tidsskr Nor Laegeforen, 126 (6), 749-52
PubMed 16541166
Medical and ventilatory treatment of acute heart failure: new insights
Cardiology, 106 (1), 1-9
DOI 10.1159/000092410, PubMed 16582544
Frequency and significance of troponin T elevation in acute ischemic stroke
Am J Cardiol, 99 (1), 108-12
DOI 10.1016/j.amjcard.2006.07.071, PubMed 17196472
Bilateral simultaneous rupture of the quadriceps tendon in an adult amateur tennis player
J Clin Rheumatol, 12 (1), 32-3
DOI 10.1097/01.rhu.0000200421.43348.05, PubMed 16484878
Time course of degradation of cardiac troponin I in patients with acute ST-elevation myocardial infarction: the ASSENT-2 troponin substudy
Circ Res, 99 (10), 1141-7
DOI 10.1161/01.RES.0000249531.23654.e1, PubMed 17038641
FDA and CPMP rulings on subgroup analyses
Cardiology, 107 (2), 97-102
DOI 10.1159/000094508, PubMed 16847375
Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study
Thromb Res, 119 (3), 277-84
DOI 10.1016/j.thromres.2006.01.019, PubMed 16563469
Effects of escalating doses of tirofiban on platelet aggregation and major receptor expression in diabetic patients: hitting the TARGET in the TENACITY trial?
Thromb Res, 119 (2), 175-81
DOI 10.1016/j.thromres.2006.02.004, PubMed 16546241
Assessment of bleeding events in clinical trials--proposal of a new classification
Am J Cardiol, 99 (2), 288-90
DOI 10.1016/j.amjcard.2006.07.091, PubMed 17223436
Publications 2005
Prevalence of diastolic dysfunction as a possible cause of dyspnea in the elderly
Am J Med, 118 (1), 25-31
DOI 10.1016/j.amjmed.2004.07.048, PubMed 15639206
[Clinical and genetic aspects of congenital insensitivity to pain with anhidrosis]
Harefuah, 144 (6), 433-7, 453, 452
PubMed 15999564
Dipyridamole decreases protease-activated receptor and annexin-v binding on platelets of post stroke patients with aspirin nonresponsiveness
Cerebrovasc Dis, 21 (1-2), 98-105
DOI 10.1159/000090207, PubMed 16340184
Noncompliance in cardiovascular clinical trials
Am Heart J, 150 (5), 882-6
DOI 10.1016/j.ahj.2005.02.039, PubMed 16290953
[Emergency room consultation policy prevents surgery delay in elderly patients with hip fractures]
Harefuah, 144 (10), 700-2, 751
PubMed 16281761
A critical appraisal of the phenomenon of aspirin resistance
Cardiology, 104 (2), 83-91
DOI 10.1159/000086690, PubMed 16020925
Publications 2004
Tolerability of beta-blocker initiation and titration with bisoprolol and carvedilol in congestive heart failure: a randomized comparison
In Cardiology, Karger, Basel, 102(2004)3, S. 160-5
BIBSYS 051908735
Tolerability of beta-blocker initiation and titration with bisoprolol and carvedilol in congestive heart failure -- a randomized comparison
Cardiology, 102 (3), 160-5
DOI 10.1159/000080485, PubMed 15334027
[Hip arthroscopy--indications, surgical technique and implementation]
Harefuah, 143 (10), 737-42, 765
PubMed 15521352
Surgical technique for an 'almost' percutaneous triple pelvic osteotomy for femoral head coverage in children 6-14 years of age
J Pediatr Orthop B, 13 (1), 57-62
DOI 10.1097/00009957-200401000-00011, PubMed 15091261
Echocardiographic indices of left ventricular diastolic dysfunction in 647 individuals with preserved left ventricular systolic function
Eur J Heart Fail, 6 (4), 439-47
DOI 10.1016/j.ejheart.2003.12.003, PubMed 15182769
Echocardiographic indices of left ventricular diastolic dysfunction in 647 individuals with preserved left ventricularsystolic function
In European journal of heart failure, Elsevier, Amsterdam, 6(2004)4, S. 439-47
BIBSYS 051927500
Noncompliance in antiplatelet trials: the AGATE trial perspective
Stroke, 35 (6), e143
DOI 10.1161/01.STR.0000126037.53283.30, PubMed 15087566
Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy
Thromb Res, 113 (3-4), 197-204
DOI 10.1016/j.thromres.2004.03.002, PubMed 15140583
Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial
Eur J Pharmacol, 499 (3), 315-24
DOI 10.1016/j.ejphar.2004.07.114, PubMed 15381054
Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGrenox versus Aspirin Therapy evaluation (AGATE) trial
In European journal of pharmacology, Elsevier, Amsterdam, 499(2004)3, S. 315-24
BIBSYS 051935473
Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy
In Thrombosis research, Pergamon Press, New York, 113(2004)3/4, S. 197-204
BIBSYS 051896826
Pharmacogenomics in cardiovascular clinical trials
Fundam Clin Pharmacol, 18 (6), 705-8
DOI 10.1111/j.1472-8206.2004.00289.x, PubMed 15548243
Pharmacogenomics in cardiovascular clinical trials
In Fundamental & clinical pharmacology, Editons Scientifiques Elsevier, Paris, 18(2004)6, S. 705-8
BIBSYS 051935880
How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?
In Journal of cardiac failure, Churchill Livingstone, Naperville, Ill., 10(2004)4, S. 297-303
BIBSYS 052021785
Hyperkaliæmi og reduceret nyrefunktion hos hjerteinsufficiente patienter under behandling spironolacton: en retrospektiv analyse af 125 konskutivt valgte patienter
In Ugeskrift for læger, Foreningen, København, 166(2004)nr. 37, S. 3201-3
BIBSYS 052021998
How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?
J Card Fail, 10 (4), 297-303
DOI 10.1016/j.cardfail.2003.10.012, PubMed 15309695
[Hyperkalemia and impaired renal function in patients taking spironolactone for congestive heart failure. A retrospective analysis of 125 consecutive cases]
Ugeskr Laeger, 166 (37), 3201-3
PubMed 15384373
Publications 2003
[Molecular modifications of troponin I and T detected in serum from patients with acute myocardial infarction]
Ugeskr Laeger, 165 (2), 116-20
PubMed 12553091
[Establishment of a nurse-led heart failure clinic. Design and baseline data from the first two years]
Ugeskr Laeger, 165 (7), 686-90
PubMed 12617047
Effect of a single dose aspirin on platelets in humans with multiple risk factors for coronary artery disease
Eur J Pharmacol, 462 (1-3), 139-43
DOI 10.1016/s0014-2999(02)02956-4, PubMed 12591106
Effect of a single dose aspirin on platelets in humans with multiple risk factors for coronary artery disease
In European journal of pharmacology, Elsevier, Amsterdam, 462(2003)1-3, s.139-43
BIBSYS 04171945x
Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets
Blood Coagul Fibrinolysis, 14 (3), 249-53
DOI 10.1097/01.mbc.0000046182.72384.ab, PubMed 12695747
Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen
Heart, 89 (12), 1422-9
DOI 10.1136/heart.89.12.1422, PubMed 14617553
Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin
Eur J Heart Fail, 5 (4), 517-21
DOI 10.1016/s1388-9842(03)00005-9, PubMed 12921813
Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials
Blood Coagul Fibrinolysis, 14 (6), 563-7
DOI 10.1097/00001721-200309000-00008, PubMed 12960610
Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials
In Blood coagulation & fibrinolysis, Rapid Communications of Oxford Ltd., Oxford, UK, 14(2003)6, s.563-7
BIBSYS 041726405
Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study
BMJ, 327 (7424), 1141-2
DOI 10.1136/bmj.327.7424.1141, PubMed 14615339
Publications 2002
Between observer variation is not eliminated by standardised analysis of dobutamine-atropine stress echocardiography
Int J Cardiovasc Imaging, 18 (3), 169-79
DOI 10.1023/a:1014660707272, PubMed 12123308
Doppler indices of diastolic transmitral flow velocity are invalid indicators of myocardial ischaemia during high-dose dobutamine infusion in anaesthetized patients
Eur J Anaesthesiol, 19 (11), 789-95
DOI 10.1017/s0265021502001278, PubMed 12442927
An integrated approach to diagnosis and therapeutic management of patients with systolic heart failure in the Copenhagen metropolitan area
Am Heart J, 144 (2), E2
DOI 10.1067/mhj.2002.123841, PubMed 12177660
Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients
J Bone Joint Surg Am, 84 (12), 2123-34
DOI 10.2106/00004623-200212000-00001, PubMed 12473698
[Fracture of the supracondylar process of the humerus associated with Monteggia fracture]
Harefuah, 141 (10), 877-8, 931
PubMed 12420591
Effects of in vitro exposure of alcohol on surface receptor expression of human platelets
Clin Physiol Funct Imaging, 22 (2), 153-6
DOI 10.1046/j.1365-2281.2002.00411.x, PubMed 12005158
Whole blood impedance aggregometry for the assessment of platelet function in patients with congestive heart failure (EPCOT Trial)
Eur J Heart Fail, 4 (4), 461-7
DOI 10.1016/s1388-9842(02)00026-0, PubMed 12167384
Failure of platelet parameters and biomarkers to correlate platelet function to severity and etiology of heart failure in patients enrolled in the EPCOT trial. With special reference to the Hemodyne hemostatic analyzer. Whole Blood Impedance Aggregometry for the Assessment of Platelet Function in Patients with Congestive Heart Failure
Pathophysiol Haemost Thromb, 32 (1), 8-15
DOI 10.1159/000057283, PubMed 12214158
Hard tissue remodeling using biofabricated coralline biomaterials
J Biochem Biophys Methods, 50 (2-3), 253-9
DOI 10.1016/s0165-022x(01)00235-4, PubMed 11741712
Publications 2001
Platelet activation as a universal trigger in the pathogenesis of acute coronary events after cocaine abuse
Swiss Med Wkly, 131 (33-34), 487-9
DOI 10.4414/smw.2001.09756, PubMed 11683077
Cardiac troponin I is modified in the myocardium of bypass patients
Circulation, 103 (1), 58-64
DOI 10.1161/01.cir.103.1.58, PubMed 11136686
Publications 2000
Comparison of methods of fractional area change for detection of regional left ventricular dysfunction
Int J Card Imaging, 16 (4), 257-66
DOI 10.1023/a:1026541122010, PubMed 11219597
Atrioventricular plane motion during dobutamine-atropine stress echocardiography: the biphasic response in healthy subjects revisited
J Am Soc Echocardiogr, 13 (10), 885-90
DOI 10.1067/mje.2000.106571, PubMed 11029711
Reduced concentrations of soluble adhesion molecules after antioxidant supplementation in postmenopausal women with high cardiovascular risk profiles--a randomized double-blind study
Cardiology, 94 (4), 227-32
DOI 10.1159/000047322, PubMed 11326143
Baseline platelet aggregation and major receptor expression predict subsequent activity following thrombolysis for acute myocardial infarction
Scand Cardiovasc J, 34 (1), 53-8
DOI 10.1080/14017430050142404, PubMed 10816061
Lack of nuclear apoptosis in cardiomyocytes and increased endothelin-1 levels in a rat heart model of myocardial stunning
Basic Res Cardiol, 95 (4), 308-15
DOI 10.1007/s003950070050, PubMed 11005586
Troponin I measurement in the diagnosis of myocardial injury during pregnancy and delivery: two cases
Am J Obstet Gynecol, 183 (5), 1308-10
DOI 10.1067/mob.2000.107460, PubMed 11084584
Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction
Circulation, 102 (11), 1221-6
DOI 10.1161/01.cir.102.11.1221, PubMed 10982534
Congenital pseudoarthrosis of the tibia
J Pediatr Orthop B, 9 (2), 103-7
DOI 10.1097/01202412-200004000-00005, PubMed 10868359
Is there a need for lumbar orthosis in mild compression fractures of the thoracolumbar spine?: A retrospective study comparing the radiographic results between early ambulation with and without lumbar orthosis
J Spinal Disord, 13 (4), 305-8
DOI 10.1097/00002517-200008000-00006, PubMed 10941889
Pathophysiology and therapeutic modification of thrombin generation in patients with coronary artery disease
Eur J Pharmacol, 402 (1-2), 1-10
DOI 10.1016/s0014-2999(00)00440-4, PubMed 10940351
The diagnostic value of Doppler echocardiographic indexes of diastolic filling for detecting demand ischemia in anesthetized patients
Int J Card Imaging, 16 (6), 437-46
DOI 10.1023/a:1010631606609, PubMed 11482709
Effect of coronary thrombolysis on the plasma concentration of osteonectin (SPARC, BM40) in patients with acute myocardial infarction
J Thromb Thrombolysis, 10 (2), 197-202
DOI 10.1023/a:1018774812613, PubMed 11005942
Publications 1999
Coral from Australian reef used to replace bone
Can Oper Room Nurs J, 17 (3), 43
PubMed 10703311
[The diabetic foot]
Harefuah, 136 (5), 403-6
PubMed 10914250
Profound ECG abnormalities during emergency cesarean section in a patient with pre-eclampsia
Scand Cardiovasc J, 33 (3), 183-6
DOI 10.1080/14017439950141849, PubMed 10399809
Results of complete soft tissue clubfoot release combined with calcaneocuboid fusion in the 4-year to 8-year age group following failed clubfoot release
J Pediatr Orthop B, 8 (3), 181-6
DOI 10.1097/01202412-199907000-00008, PubMed 10399120
Increased soluble platelet/endothelial cellular adhesion molecule-1 and osteonectin levels in patients with severe congestive heart failure. Independence of disease etiology, and antecedent aspirin therapy
Eur J Heart Fail, 1 (3), 243-9
DOI 10.1016/s1388-9842(99)00029-x, PubMed 10935670
Isolation, electron microscopic imaging, and 3-D visualization of native cardiac thin myofilaments
J Struct Biol, 126 (2), 98-104
DOI 10.1006/jsbi.1999.4111, PubMed 10388621
Publications 1998
Multiple dorsal dislocations of the metacarpophalangeal joints: a case report and review of the literature
Am J Orthop (Belle Mead NJ), 27 (4), 313-4
PubMed 9586731
[Vacuum phenomenon in the hip joint: diagnostic value]
Harefuah, 135 (3-4), 108-9, 167
PubMed 9885654
Pregnancy-associated osteoporosis: preliminary densitometric evidence of extremely rapid recovery of bone mineral density
South Med J, 91 (1), 33-5
DOI 10.1097/00007611-199801000-00006, PubMed 9438399
Distinct subcellular localization of calcium binding S100 proteins in human smooth muscle cells and their relocation in response to rises in intracellular calcium
J Cell Sci, 111 ( Pt 14), 2043-54
DOI 10.1242/jcs.111.14.2043, PubMed 9645951
[The painful shoulder--differential diagnosis, assessment and treatment]
Harefuah, 134 (7), 563-9
PubMed 10909605
[Necrotizing soft tissue infection]
Harefuah, 134 (9), 695-7, 750
PubMed 10909616
Dobutamine stress echocardiography to detect inducible demand ischemia in anesthetized patients with coronary artery disease
Anesthesiology, 88 (5), 1233-9
DOI 10.1097/00000542-199805000-00014, PubMed 9605683
Changes in hemostasis after parenteral magnesium in myocardial ischemia-reperfusion: from animal studies to clinical trials
Magnes Res, 11 (2), 133-40
PubMed 9675757
[Pelvic lytic lesion, and the need to suspect osteoporosis-related fractures]
Harefuah, 134 (4), 269-70, 335
PubMed 10909503
Publications 1997
[Myocardial reperfusion: salvation or danger for the heart muscle? Stunning, hibernation and preconditioning: the states of endogenous cardiac protection against ischemia]
Schweiz Med Wochenschr, 127 (48), 2008-13
PubMed 9490468
[Can myocardial damage following heart infarct be reversible?]
Praxis (Bern 1994), 86 (11), 421-4
PubMed 9190643
Carnitine--from cellular mechanisms to potential clinical applications in heart disease
Eur J Clin Invest, 27 (12), 973-6
DOI 10.1046/j.1365-2362.1997.2360783.x, PubMed 9466122
Role of troponin I proteolysis in the pathogenesis of stunned myocardium
Circ Res, 80 (3), 393-9
PubMed 9048660
[Combined treatment for adhesive capsulitis of the shoulder]
Harefuah, 133 (9), 357-9, 415
PubMed 9418336
[Fractures of the calcaneus--new trends in management]
Harefuah, 132 (6), 424-7
PubMed 9153862
Bilateral dislocation of the hip during convulsions: a case report
J Bone Joint Surg Br, 79 (2), 304-6
DOI 10.1302/0301-620x.79b2.7144, PubMed 9119862
Publications 1996
[Pregnancy-associated osteoporosis]
Harefuah, 130 (5), 344-6
PubMed 8707183
[Arthroscopic surgery of the knee with CO2 laser surgery of the knee]
Harefuah, 131 (3-4), 76-8, 144
PubMed 8854485
Publications 1995
The diagnostic value of exercise echocardiography in ischemic heart disease in relation to quantitative coronary arteriography
Int J Card Imaging, 11 (1), 1-7
DOI 10.1007/BF01148948, PubMed 7730677
Excitation-transcription coupling mediated by zinc influx through voltage-dependent calcium channels
J Biol Chem, 270 (6), 2473-7
DOI 10.1074/jbc.270.6.2473, PubMed 7852308
Alterations of excitation-contraction coupling in stunned myocardium and in failing myocardium
J Mol Cell Cardiol, 27 (2), 783-91
DOI 10.1016/0022-2828(95)90085-3, PubMed 7776385
Combined hip surgery in cerebral palsy patients
Am J Orthop (Belle Mead NJ), 24 (1), 52-5
PubMed 7773656
Femoral varus derotational osteotomy in cerebral palsy
Am J Orthop (Belle Mead NJ), 24 (4), 337-41
PubMed 7788313
Hip dislocation caused by infantile myofibromatosis
Am J Orthop (Belle Mead NJ), 24 (10), 774-6
PubMed 8593559
Relationship between intracellular calcium and contractile force in stunned myocardium. Direct evidence for decreased myofilament Ca2+ responsiveness and altered diastolic function in intact ventricular muscle
Circ Res, 76 (6), 1036-48
DOI 10.1161/01.res.76.6.1036, PubMed 7758158
Highlights of talipes equinovarus deformity
Am J Orthop (Belle Mead NJ), 24 (5), 393-9
PubMed 7620861
Reactivity of coronary arteries in relation to serum magnesium levels in patients with ischaemic heart disease--a quantitative coronary angiographic study
Magnes Res, 8 (1), 57-63
PubMed 7669508
Bilateral hypoplastic lateral meniscus
Arthroscopy, 11 (6), 740-2
DOI 10.1016/0749-8063(95)90121-3, PubMed 8679040
Publications 1994
Assessment of coronary artery stenosis pressure gradient by quantitative coronary arteriography in patients with coronary artery disease
Clin Physiol, 14 (1), 23-35
DOI 10.1111/j.1475-097x.1994.tb00486.x, PubMed 8149707
Accuracy of quantification of coronary arteriograms with hand-held calipers. A validation study
Cardiology, 85 (2), 94-100
DOI 10.1159/000176655, PubMed 7954569
Effects of magnesium supplementation in a porcine model of myocardial ischemia and reperfusion
J Cardiovasc Pharmacol, 24 (4), 603-11
DOI 10.1097/00005344-199410000-00011, PubMed 7528843
A canine model of acute coronary artery thrombosis for the evaluation of reperfusion strategies
Cardiology, 84 (1), 1-8
DOI 10.1159/000176322, PubMed 8149384
Magnesium and myocardial infarction
Lancet, 343 (8908), 1285-6
PubMed 7910287
Magnesium deficiency prolongs myocardial stunning in an open-chest swine model
Int J Cardiol, 47 (2), 105-15
DOI 10.1016/0167-5273(94)90176-7, PubMed 7721477
Minor knee trauma as a possible cause of asymmetrical proximal tibial physis closure. A case report
Clin Orthop Relat Res (307), 142-5
PubMed 7924026
Publications 1993
Complete soft-tissue clubfoot release with and without internal fixation
Orthop Rev, 22 (9), 1015-6
PubMed 8247617
CT-guided excision of osteoid osteoma
AJR Am J Roentgenol, 160 (1), 211
DOI 10.2214/ajr.160.1.8416636, PubMed 8416636
Excision of the posterior tibial tendon during clubfoot release
Foot Ankle, 14 (3), 123-4
DOI 10.1177/107110079301400302, PubMed 8491424
Tarsal navicular position after complete soft-tissue clubfoot release
Clin Orthop Relat Res (295), 252-8
PubMed 8403657
Pavlik harness versus Frejka splint in treatment of developmental dysplasia of the hip: bicenter study
J Pediatr Orthop, 13 (3), 311-3
DOI 10.1097/01241398-199305000-00006, PubMed 8496362
Coenzyme Q10 protects ischemic myocardium in an open-chest swine model
Clin Investig, 71 (8 Suppl), S103-11
DOI 10.1007/BF00226849, PubMed 8241692
Effect of distal hamstring release on cerebral palsy patients
Bull Hosp Jt Dis, 53 (1), 34-6
PubMed 8374489
Postpoliomyelitis syndrome problems of knee function: a review
Bull Hosp Jt Dis, 53 (4), 27-9
PubMed 8829592
Effect of magnesium sulphate infusion on ex vivo platelet aggregation in swine
Magnes Res, 6 (4), 349-53
PubMed 8155486
Use of tissue expansion in clubfoot surgery
Foot Ankle, 14 (3), 117-22
DOI 10.1177/107110079301400301, PubMed 8491423
Publications 1992
Intermetatarsal synostosis after treatment with Ilizarov apparatus: a case report
Bull Hosp Jt Dis, 52 (1), 12
PubMed 1422434
2-D and 3-D computed tomography and magnetic resonance imaging in developmental dysplasia of the hip
Orthop Rev, 21 (10), 1189-97
PubMed 1437247
Tips of the trade. Computerized tomography--guided excision of osteoid osteoma
Orthop Rev, 21 (12), 1457-8
PubMed 1465308
Discitis in children
Orthop Rev, 21 (8), 931-3
PubMed 1523007
New method of limb deformities correction in children
Bull N Y Acad Med, 68 (4), 447-69
PubMed 1490205
Revision surgery in clubfeet
Clin Orthop Relat Res (283), 223-30
PubMed 1395251
The Ilizarov apparatus for treatment of melorheostosis. Case report and review of the literature
Clin Orthop Relat Res (281), 163-7
PubMed 1499204
Pin care using the Ilizarov apparatus: recommended treatment plan in Kurgan, Russia
Bull Hosp Jt Dis, 52 (1), 18-20
PubMed 1422437
The Ilizarov technique in correction of complex foot deformities
Clin Orthop Relat Res (280), 94-103
PubMed 1611769
Pelvic osteotomies in children
Bull N Y Acad Med, 68 (4), 483-96
PubMed 1490207
Carpal canal stenosis in men with idiopathic carpal tunnel syndrome
Clin Orthop Relat Res (285), 210-3
PubMed 1446439
Publications 1991
Growing pains
Orthop Rev, 20 (2), 133-6
PubMed 2008312
Complications in clubfoot surgery
Orthop Rev, 20 (3), 233-9
PubMed 2023786
Pavlik harness pathology
Isr J Med Sci, 27 (6), 325-30
PubMed 2061019
Percutaneous epiphysiodesis
J Bone Joint Surg Br, 73 (1), 173
DOI 10.1302/0301-620X.73B1.1991759, PubMed 1991759
Treatment of complex limb deformities in children with the Ilizarov technique
Orthopedics, 14 (9), 961-7
DOI 10.3928/0147-7447-19910901-07, PubMed 1946060
Fractional lengthening of the flexor tendons in clubfoot surgery
Clin Orthop Relat Res (264), 267-9
PubMed 1997245
Ilizarov technique in treatment of congenital hand anomalies. Two case reports
Clin Orthop Relat Res (273), 268-74
PubMed 1659962
Preventing and overcoming equinus contractures during lengthening of the tibia
Orthop Clin North Am, 22 (4), 633-41
PubMed 1945341
Rehabilitation of the hand after an explosion injury
Am J Occup Ther, 45 (10), 937-40
DOI 10.5014/ajot.45.10.937, PubMed 1951620
Publications 1990
New approach to limb deformities in neuromuscular patients
Bull Hosp Jt Dis Orthop Inst, 50 (2), 99-106
PubMed 2175670
Triple arthrodesis
Foot Ankle, 11 (1), 45-6
DOI 10.1177/107110079001100109, PubMed 2210533
Intra-operative arthrography in open reduction of congenital hip dislocation
J Bone Joint Surg Br, 72 (3), 526
DOI 10.1302/0301-620X.72B3.2341468, PubMed 2341468
The use of a tissue expander in club-foot surgery. A case report and review
J Bone Joint Surg Br, 72 (4), 574-7
DOI 10.1302/0301-620X.72B4.2380206, PubMed 2380206
Revision surgery in clubfeet
Bull Hosp Jt Dis Orthop Inst, 50 (2), 149-59
PubMed 2175661
Pediatric update #12. A simplified method for percutaneous epiphysiodesis
Orthop Rev, 19 (4), 358-9, 362-4
PubMed 2185455
Pediatric update #14. Functional rating system for evaluating the results of clubfoot surgery
Orthop Rev, 19 (8), 730-5
PubMed 2216546
Ilizarov technique in correction of foot deformities: a preliminary report
Foot Ankle, 11 (1), 1-5
DOI 10.1177/107110079001100101, PubMed 2210527
Cannulated blade plate for proximal femoral varus osteotomy
Clin Orthop Relat Res (259), 111-3
PubMed 2208844
Neck metaphyseal angle guidance in proximal femoral varus osteotomy
J Pediatr Orthop, 10 (1), 9-13
PubMed 2298902
Re-do clubfoot: surgical approach and long-term results
Bull N Y Acad Med, 66 (6), 601-17
PubMed 2282442
Characterization of the fine specificity of peptide antibodies to HLA-DQ beta-chain molecules
Biomed Biochim Acta, 49 (12), 1223-32
PubMed 1711320
[Anemia, abnormal ECG, shock]
Schweiz Rundsch Med Prax, 79 (9), 237-42
PubMed 2333451
Publications 1989
Site-specific antibodies distinguish single amino acid substitutions in position 57 in HLA-DQ beta-chain alleles associated with insulin-dependent diabetes
J Immunol, 143 (2), 533-8
PubMed 2738402